<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Zhu Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Stroke is a devastating global health issue, with high mortality and disability rates. The increasing prevalence of male infertility among reproductive-aged men has become a growing concern worldwide. However, the relationship between male infertility and stroke incidence remains uncertain. This study aimed to address this knowledge gap by employing a Mendelian randomization (MR) approach.&lt;h4>Method&lt;/h4>Utilizing genetic instrumental variables derived from a genome-wide association study (GWAS) on male infertility and stroke, a two-sample MR design was implemented. Five different analysis methods, with inverse-variance weighted as the primary approach, were used to examine the genetic causal associations between male infertility and various stroke subtypes. Heterogeneity analysis, pleiotropy tests, and leave-one-out validation were conducted to assess heterogeneity, evaluate pleiotropy, and ensure the robustness of the findings.&lt;h4>Result&lt;/h4>The results indicate a potential lower risk of small vessel stroke associated with male infertility (odds ratio, 95% confidence interval: 0.82, 0.68 to 0.99, &lt;i>p&lt;/i>=0.044), although no significant impact on other stroke subtypes was observed. The study exhibited low heterogeneity and no apparent pleiotropy; however, the stability of the results was not optimal.&lt;h4>Conclusion&lt;/h4>Male infertility might potentially confer a protective effect against small vessel stroke risk. Caution is warranted due to potential confounding factors. Additional studies are necessary to confirm these findings and provide further validation.</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>1338077</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11056502</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Causal associations of male infertility with stroke: a two-sample Mendelian randomization study.</pubmed_title><pmcid>PMC11056502</pmcid><pubmed_authors>Zhu Y</pubmed_authors><pubmed_authors>Guan S</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Dong L</pubmed_authors><pubmed_authors>Xin X</pubmed_authors><pubmed_authors>Yu Z</pubmed_authors><pubmed_authors>Ye Y</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Causal associations of male infertility with stroke: a two-sample Mendelian randomization study.</name><description>&lt;h4>Background&lt;/h4>Stroke is a devastating global health issue, with high mortality and disability rates. The increasing prevalence of male infertility among reproductive-aged men has become a growing concern worldwide. However, the relationship between male infertility and stroke incidence remains uncertain. This study aimed to address this knowledge gap by employing a Mendelian randomization (MR) approach.&lt;h4>Method&lt;/h4>Utilizing genetic instrumental variables derived from a genome-wide association study (GWAS) on male infertility and stroke, a two-sample MR design was implemented. Five different analysis methods, with inverse-variance weighted as the primary approach, were used to examine the genetic causal associations between male infertility and various stroke subtypes. Heterogeneity analysis, pleiotropy tests, and leave-one-out validation were conducted to assess heterogeneity, evaluate pleiotropy, and ensure the robustness of the findings.&lt;h4>Result&lt;/h4>The results indicate a potential lower risk of small vessel stroke associated with male infertility (odds ratio, 95% confidence interval: 0.82, 0.68 to 0.99, &lt;i>p&lt;/i>=0.044), although no significant impact on other stroke subtypes was observed. The study exhibited low heterogeneity and no apparent pleiotropy; however, the stability of the results was not optimal.&lt;h4>Conclusion&lt;/h4>Male infertility might potentially confer a protective effect against small vessel stroke risk. Caution is warranted due to potential confounding factors. Additional studies are necessary to confirm these findings and provide further validation.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-04-30T21:22:02.751Z</modification><creation>2026-04-07T16:21:30.93Z</creation></dates><accession>S-EPMC11056502</accession><cross_references><pubmed>38686206</pubmed><doi>10.3389/fendo.2024.1338077</doi></cross_references></HashMap>